 Core Laboratories N.V. NYSE: CLB US and Euronext Amsterdam: CLB NA Core, Core Lab, or the Company reported that continuing operations resulted in second quarter 2020 revenue of 115,700,000. The financial results for the second quarter of 2020 include a charge of 13,300,000 associated with: 1 severance in connection with on-going cost reduction initiatives, 2 a non-cash inventory write-down, and 3 other non-cash charges. Cores operating loss was 2,600,000, with a loss per diluted share of 0.13, all in accordance with U.S. generally accepted accounting principles GAAP. Operating income, ex-items, a non-GAAP financial measure, was 10,700,000, yielding operating margins of 9.2 and earnings per diluted share EPS, ex-items, of 0.14. A full reconciliation of non-GAAP financial measures is included in the attached financial tables. 